Partheepan Narendran

Professor Partheepan Narendran serves as a Professor in Diabetes Medicine at the Immunology and Immunotherapy Centre for Endocrinology, Diabetes and Metabolism, University of Birmingham. He maintains active clinical appointments at Birmingham Heartlands Hospital (since 2015) and Queen Elizabeth Hospital (since 2005), bridging clinical practice with cutting-edge diabetes research.

His research focuses on autoimmunity and type 1 diabetes, particularly exploring peripheral immune tolerance to diabetes antigens and investigating how insulin resistance interacts with autoimmunity in diabetes development. His work profile shows dominant emphasis on Type 1 Diabetes Mellitus (100%), Type I Diabetes (84%), and Insulin Dependent Diabetes Mellitus (76%), with significant contributions to understanding Diabetic Ketoacidosis and Hemoglobin A1c monitoring.

Professor Narendran's publication trajectory reveals a strategic shift toward early intervention and prevention strategies, with recent work emphasizing immunomodulatory therapies, beta cell preservation, and novel screening approaches. His 2025 publications highlight multi-center collaborations across the UK healthcare system, focusing on practical implementation of diabetes care improvements.

• Active supervisor of academic foundation trainees, clinical fellows, PhD and MD researchers
• Principal or co-investigator on 10 currently active research projects
• Total of 46 research projects throughout his career
• 177 total research outputs documented

His external appointments include the NIHR Research for Patient Benefit panel West Midlands (since 2014), Diabetes UK (since 2015), and previous service with the Diabetes Research Wellness Foundation (2010-2015), demonstrating sustained commitment to advancing diabetes care and research at national levels.